The United States’ standing as an important place for cancer research is under threat. As the New York Times reports, the Trump administration has dramatically slashed funding to US-based cancer research, endangering the country’s overall leading position in science research — not to mention the fates of cancer patients across the country. Federal cancer research, in particular, has seen drastic reductions, which critics say will hamper any advancement in finding effective treatments. The implications are enormous — approximately 38.9 percent of Americans are expected to be diagnosed with cancer at some point in their lives, according to the National Cancer Institute. More on cancer research: RFK Jr. Cancels Promising Work on Cancer Vaccine